Researchers at the Pasteur Institute in Tunisia have been studying genetic factors that may contribute to cognitive decline in diabetics and their progression to Alzheimer's disease since 2023. The goal is to develop an early detection method to improve care for those at risk. According to Professor Rim Kafi, a geneticist at the institute, recent studies suggest that around 70% of diabetics are at risk of cognitive decline, increasing their likelihood of developing Alzheimer's.
The research team is currently conducting a study involving 100 diabetic patients to identify scientific indicators that can help understand the relationship between the two diseases and detect those at risk of developing Alzheimer's. The study aims to determine genetic markers that can predict the progression of Alzheimer's in diabetics. Professor Kafi noted that the study is ongoing and is expected to be expanded to include a larger sample size.
The research has the potential to lead to the development of a blood test and genetic screening for diabetics to determine their risk of developing Alzheimer's. This would enable early intervention and potentially slow down the progression of the disease. The study's findings are expected to be available in the coming years. According to experts, early detection of individuals at risk can facilitate prevention and monitoring of their health.
The study's focus on genetic factors associated with Alzheimer's in diabetics is crucial, as it may help identify those who would benefit from early intervention. The research team's efforts are part of a broader initiative to improve the prevention and care of Alzheimer's disease in Tunisia. A recent scientific day organized by the city of sciences in Tunis and the Alzheimer's Association highlighted the importance of this research.
The development of a blood test for early detection of Alzheimer's in diabetics would be a significant breakthrough in the management of the disease. Alzheimer's is a major public health concern, and early detection can help alleviate the burden on healthcare systems. The research at the Pasteur Institute is an important step towards achieving this goal.
Experts emphasize that prevention and control of risk factors are essential in reducing the progression of Alzheimer's disease. The research at the Pasteur Institute is part of a broader effort to promote prevention and early intervention. The National Campaign "October Rose" to detect breast cancer is also underway, highlighting the importance of preventive measures in maintaining public health.
The research at the Pasteur Institute is expected to contribute significantly to the understanding of Alzheimer's disease and its relationship with diabetes. The study's findings will be crucial in developing effective strategies for early detection and prevention of the disease. The institute's efforts are a testament to Tunisia's commitment to advancing medical research and improving public health.
Key points
- Researchers at Pasteur Institute are developing a blood test to detect Alzheimer's disease in diabetics.
- The study aims to identify genetic markers that can predict the progression of Alzheimer's in diabetics.
- Early detection of individuals at risk can facilitate prevention and monitoring of their health.
